Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Systemic Erythropoietin for Optic Atrophy
NCT04680143Phase 2Completed
- Sponsor
- Alexandria University
- Start
- Sep 2020
- Primary completion
- Mar 2021
- Modality
- Biologic, rProtein (Recombinant Protein)
- Countries
- 1
01
Overview
A Phase 2 trial of epoetin alfa in optic atrophy, sponsored by Alexandria University. Started Sep 2020; status: completed.
02
Drugs
epoetin alfa
03
Conditions
optic atrophy
Beyond the preview
Go deeper on NCT04680143.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04680143.